State-of-the-art imaging technology enables noninvasive methods for quantifying morphological and functional biomarkers in clinical and preclinical studies.
The Imaging Unit of the CRC Hannover has been equipped with its own MRI scanner. It will be used exclusively for research, specifically to support early-phase clinical trials of new pharmaceuticals. MR technology permits fast, accurate data capture and is also noninvasive with minimal impacts on study participants. While drawing on the excellent infrastructure of the CRC Hannover and the expertise of the MHH and Fraunhofer ITEM scientists working in this study center, the radiologists and neuroradiologists of the Imaging Unit are in a position to offer state-of-the-art examination and analysis methods to clients in industry.